The X chromosome and the sex ratio of autoimmunity

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Selmi, Carlo ^a,b   Brunetta, Enrico ^b   Raimondo, Maria Gabriella ^b   Meroni, Pier Luigi ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POLYAMINE;

ADDISON DISEASE; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE CHRONIC HEPATITIS; AUTOIMMUNE DISEASE; EPIGENETICS; FEMALE; GENE ACTIVATION; GENE INACTIVATION; GENETIC SUSCEPTIBILITY; GIANT CELL ARTERITIS; GRAVES DISEASE; HAPLOINSUFFICIENCY; HASHIMOTO DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOSAICISM; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYOSITIS; PERNICIOUS ANEMIA; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; RHEUMATOID ARTHRITIS; SEX RATIO; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; X CHROMOSOME;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHROMOSOMES, HUMAN, X; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; SEX FACTORS; SEX RATIO; X CHROMOSOME INACTIVATION;

EID: 84858437508     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.024     Document Type: Review

References (120)

1. Shoenfeld Y., Selmi C., Zimlichman E., Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008, 31:325-330.
2. Adams D.D., Knight J.G., Ebringer A. Autoimmune diseases: solution of the environmental, immunological and genetic components with principles for immunotherapy and transplantation. Autoimmun Rev 2010, 9:525-530.
3. Arora-Singh R.K., Assassi S., del Junco D.J., Arnett F.C., Perry M., Irfan U., et al. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun 2010, 35:52-57.
4. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 2007, 28:1-6.
5. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007, 29:1-9.
6. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7:626-630.
7. Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol 2008, 22:913-922.
8. Medina K.L., Garrett K.P., Thompson L.F., Rossi M.I., Payne K.J., Kincade P.W. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol 2001, 2:718-724.
9. Medina K.L., Kincade P.W. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 1994, 91:5382-5386.
10. Grimaldi C.M., Cleary J., Dagtas A.S., Moussai D., Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002, 109:1625-1633.
11. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 2005, 31:91-106.
12. Peeva E. Reproductive immunology: current status and future directions (part I). Clin Rev Allergy Immunol 2010, 39:143-147.
13. Peeva E. Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors. Clin Rev Allergy Immunol 2011, 40:1-7.
14. Ambrosio P., Lermann R., Cordeiro A., Borges A., Nogueira I., Serrano F. Lupus and pregnancy - 15years of experience in a tertiary center. Clin Rev Allergy Immunol 2010, 38:77-81.
15. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
16. Andreoli L., Bazzani C., Taraborelli M., Reggia R., Lojacono A., Brucato A., et al. Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmun Rev 2010, 10:51-54.
17. Prince M.I., Ducker S.J., James O.F. Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut 2010, 59:508-512.
18. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005, 42:1194-1202.
19. Bogdanos D.P., Choudhuri K., Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001, 21:225-232.
20. Rieger R., Gershwin M.E. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007, 28:76-84.
21. Wakabayashi K., Lian Z.X., Leung P.S., Moritoki Y., Tsuneyama K., Kurth M.J., et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008, 48:531-540.
22. Coulter E.M., Farrell J., Mathews K.L., Maggs J.L., Pease C.K., Lockley D.J., et al. Activation of human dendritic cells by p-phenylenediamine. J Pharmacol Exp Ther 2007, 320:885-892.
23. Lim S.Y., Ghosh S.K. Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells. Immunology 2004, 112:94-104.
24. Lim S.Y., Ghosh S.K. Autoreactive responses to an environmental factor: 1. Phthalate induces antibodies exhibiting anti-DNA specificity. Immunology 2003, 110:482-492.
25. Maloney S., Smith A., Furst D.E., Myerson D., Rupert K., Evans P.C., et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999, 104:41-47.
26. Murata H., Nakauchi H., Sumida T. Microchimerism in Japanese women patients with systemic sclerosis. Lancet 1999, 354:220.
27. Adams K.M., Nelson J.L. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004, 291:1127-1131.
28. Invernizzi P., Biondi M.L., Battezzati P.M., Perego F., Selmi C., Cecchini F., et al. Presence of fetal DNA in maternal plasma decades after pregnancy. Hum Genet 2002, 110:587-591.
29. Gammill H.S., Guthrie K.A., Aydelotte T.M., Waldorf K.M., Nelson J.L. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?. Blood 2010, 116:2706-2712.
30. Adams Waldorf K.M., Nelson J.L. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol Invest 2008, 37:631-644.
31. Nelson J.L., Gillespie K.M., Lambert N.C., Stevens A.M., Loubiere L.S., Rutledge J.C., et al. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci USA 2007, 104:1637-1642.
32. Chan W.F., Atkins C.J., Naysmith D., van der Westhuizen N., Woo J., Nelson J.L. Microchimerism in the rheumatoid nodules of rheumatoid arthritis patients. Arthritis Rheum 2011.
33. Greer L.G., Casey B.M., Halvorson L.M., Spong C.Y., McIntire D.D., Cunningham F.G. Antithyroid antibodies and parity: further evidence for microchimerism in autoimmune thyroid disease. Am J Obstet Gynecol 2011, 205. 471 e1-4.
34. Gadi V.K., Nelson J.L. Fetal microchimerism in women with breast cancer. Cancer Res 2007, 67:9035-9038.
35. Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev 2010;10:594-604.
36. Migeon B.R. The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. JAMA 2006, 295:1428-1433.
37. Morris J.A., Harrison L.M. Hypothesis: increased male mortality caused by infection is due to a decrease in heterozygous loci as a result of a single X chromosome. Med hypotheses 2009, 72:322-324.
38. Spolarics Z. The X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infection. Shock 2007, 27:597-604. Augusta, Ga,.
39. Lambert N.C. The price of silence. Arthritis Rheum 2009, 60:3164-3167.
40. Uz E., Mustafa C., Topaloglu R., Bilginer Y., Dursun A., Kasapcopur O., et al. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:3410-3412.
41. Lambert N.C. The price of silence. Arthritis Rheum 2009, 60:3164-3167.
42. Abkowitz J.L., Linenberger M.L., Persik M., Newton M.A., Guttorp P. Behavior of feline hematopoietic stem cells years after busulfan exposure. Blood 1993, 82:2096-2103.
43. Ozbalkan Z., Bagislar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570.
44. Meda F., Folci M., Baccarelli A., Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol 2011, 8:226-236.
45. Hellman A., Chess A. Gene body-specific methylation on the active X chromosome. Science 2007, 315:1141-1143. New York, NY,.
46. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404.
47. Aspinall R. Longevity and the immune response. Biogerontology 2000, 1:273-278.
48. Choudhry M.A., Bland K.I., Chaudry I.H. Gender and susceptibility to sepsis following trauma. Endocr Metab Immune Disord Drug Targets 2006, 6:127-135.
49. Gannon C.J., Pasquale M., Tracy J.K., McCarter R.J., Napolitano L.M. Male gender is associated with increased risk for postinjury pneumonia. Shock 2004, 21:410-414. Augusta, Ga,.
50. Green M.S. The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int J Epidemiol 1992, 21:381-386.
51. Restif O, Amos W. The evolution of sex-specific immune defences. Proc Biol Sci 2010;277(1691):2247-55.
52. Butterworth M., McClellan B., Allansmith M. Influence of sex in immunoglobulin levels. Nature 1967, 214:1224-1225.
53. Purtilo DT, Sullivan JL. Immunological bases for superior survival of females. American journal of diseases of children (1960), 1979;133:1251-3.
54. Migeon B.R. Why females are mosaics, X-chromosome inactivation, and sex differences in disease. Gend Med 2007, 4:97-105.
55. Glezen W.P., Loda F.A., Clyde W.A., Senior R.J., Sheaffer C.I., Conley W.G., et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr 1971, 78:397-406.
56. Hall C.B., Kopelman A.E., Douglas R.G., Geiman J.M., Meagher M.P. Neonatal respiratory syncytial virus infection. N Engl J Med 1979, 300:393-396.
57. Thompson D.J., Gezon H.M., Rogers K.D., Yee R.B., Hatch T.F. Excess risk of staphylococcal infection and disease in newborn males. Am J Epidemiol 1966, 84:314-328.
58. Strachan N.J., Watson R.O., Novik V., Hofreuter D., Ogden I.D., Galan J.E. Sexual dimorphism in campylobacteriosis. Epidemiol Infect 2008, 136:1492-1495.
59. Notarangelo L., Casanova J.L., Conley M.E., Chapel H., Fischer A., Puck J., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 2006, 117:883-896.
60. Leonard W.J. Cytokines and immunodeficiency diseases. Nat Rev 2001, 1:200-208.
61. Mordmuller B., Turrini F., Long H., Kremsner P.G., Arese P. Neutrophils and monocytes from subjects with the Mediterranean G6PD variant: effect of Plasmodium falciparum hemozoin on G6PD activity, oxidative burst and cytokine production. Eur Cytokine Netw 1998, 9:239-245.
62. Wilmanski J., Siddiqi M., Deitch E.A., Spolarics Z. Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages. J Leukoc Biol 2005, 78:85-94.
63. Ozcelik T. X chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol 2008, 34:348-351.
64. Kast R.E. Predominance of autoimmune and rheumatic diseases in females. J Rheumatol 1977, 4:288-292.
65. Stewart J.J. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 1998, 19:352-357.
66. Takeno M., Nagafuchi H., Kaneko S., Wakisaka S., Oneda K., Takeba Y., et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J Immunol 1997, 158:3529-3538.
67. Takeno M., Nagafuchi H., Kaneko S., Wakisaka S., Oneda K., Takeba Y., et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J Immunol 1997, 158:3529-3538.
68. Brix T.H., Knudsen G.P., Kristiansen M., Kyvik K.O., Orstavik K.H., Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metabol 2005, 90:5949-5953.
69. Ozbalkan Z., Bagislar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570.
70. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 2006, 14:791-797.
71. Uz E., Loubiere L.S., Gadi V.K., Ozbalkan Z., Stewart J., Nelson J.L., et al. Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol 2008, 34:352-355.
72. Invernizzi P. The X chromosome in female-predominant autoimmune diseases. Ann N Y Acad Sci 2007, 1110:57-64.
73. Chitnis S., Monteiro J., Glass D., Apatoff B., Salmon J., Concannon P., et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2000, 2:399-406.
74. Scofield R.H., Bruner G.R., Namjou B., Kimberly R.P., Ramsey-Goldman R., Petri M., et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008, 58:2511-2517.
75. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
76. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
77. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010, 35:265-268.
78. Forsdyke D.R. X chromosome reactivation perturbs intracellular self/not-self discrimination. Immunol Cell Biol 2009, 87:525-528.
79. Zhou Y., Yuan J., Pan Y., Fei Y., Qiu X., Hu N., et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol 2009, 132:362-370.
80. Lleo A., Liao J., Invernizzi P., Zhao M., Bernuzzi F., Ma L., et al. IgM levels inversely correlate with cd40l promoter methylation in patients with primary biliary cirrhosis Hepatology-Ana lleo library 4-26. Hepatology 2012, 55(1):153-160.
81. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 2006, 103:9970-9975.
82. Smith-Bouvier D.L., Divekar A.A., Sasidhar M., Du S., Tiwari-Woodruff S.K., King J.K., et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008, 205:1099-1108.
83. Invernizzi P. The X chromosome in female-predominant autoimmune diseases. Ann N Y Acad Sci 2007, 1110:57-64.
84. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005, 175:575-578.
85. Ranke M.B., Saenger P. Turner's syndrome. Lancet 2001, 358:309-314.
86. Elsheikh M., Wass J.A., Conway G.S. Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype. Clin Endocrinol 2001, 55:223-226.
87. Sybert V.P., McCauley E. Turner's syndrome. N Engl J Med 2004, 351:1227-1238.
88. Bondy C.A., Cheng C. Monosomy for the X chromosome. Chromosome Res 2009, 17:649-658.
89. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005, 175:575-578.
90. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004, 363:533-535.
91. Mitchell M.M., Lleo A., Zammataro L., Mayo M.J., Invernizzi P., Bach N., et al. Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 2011, 6:95-102.
92. Brooks W.H. X chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol 2010, 39(1):20-29.
93. Wallace H.M., Fraser A.V., Hughes A. A perspective of polyamine metabolism. Biochem J 2003, 376:1-14.
94. Casero R.A., Marton L.J. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 2007, 6:373-390.
95. Hobbs C.A., Gilmour S.K. High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. J Cell Biochem 2000, 77:345-360.
96. Poduslo J.F., Curran G.L. Polyamine modification increases the permeability of proteins at the blood-nerve and blood-brain barriers. J Neurochem 1996, 66:1599-1609.
97. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell Signal 1997, 9:1-13.
98. Maeda Y., Rachez C., Hawel L., Byus C.V., Freedman L.P., Sladek F.M. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Mol Endocrinol 2002, 16:1502-1510. Baltimore, Md,.
99. Thomas T., Kiang D.T. A twenty-two-fold increase in the relative affinity of estrogen receptor to poly (dA-dC).poly (dG-dT) in the presence of polyamines. Nucleic Acids Res 1988, 16:4705-4720.
100. Kleppe K., Osland A., Fosse V., Male R., Lossius I., Helland D., et al. Effect of polyamines on enzymes involved in DNA repair. Med Biol 1981, 59:374-380.
101. Hasan R., Alam M.K., Ali R. Polyamine induced Z-conformation of native calf thymus DNA. FEBS Lett 1995, 368:27-30.
102. Brooks W.H. Systemic lupus erythematosus and related autoimmune diseases are antigen-driven, epigenetic diseases. Med hypotheses 2002, 59:736-741.
103. Ballestar E. Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 2011, 7:263-271.
104. Ballestar E. Epigenetics lessons from twins: prospects for autoimmune disease. Clin Rev Allergy Immunol 2010, 39:30-41.
105. Javierre B.M., Esteller M., Ballestar E. Epigenetic connections between autoimmune disorders and haematological malignancies. Trends Immunol 2008, 29:616-623.
106. Chagnon P., Schneider R., Hebert J., Fortin P.R., Provost S., Belisle C., et al. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum 2006, 54:1270-1278.
107. Sawalha A.H., Harley J.B., Scofield R.H. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 2009, 33:31-34.
108. Brandrup F., Koch C., Petri M., Schiodt M., Johansen K.S. Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. Br J Dermatol 1981, 104:495-505.
109. Invernizzi P., Miozzo M., Oertelt-Prigione S., Meroni P.L., Persani L., Selmi C., et al. X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1110:84-91.
110. Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol 2008, 22:913-922.
111. Arber S., McKinlay J., Adams A., Marceau L., Link C., O'Donnell A. Patient characteristics and inequalities in doctors' diagnostic and management strategies relating to CHD: a video-simulation experiment. Soc Sci Med 2006, 62:103-115.
112. Gale E.A., Gillespie K.M. Diabetes and gender. Diabetologia 2001, 44:3-15.
113. Lu Q., Renaudineau Y., Cha S., Ilei G., Brooks W.H., Selmi C., et al. Epigenetics in autoimmune disorders: highlights of the 10th Sjogren's syndrome symposium. Autoimmun Rev 2010, 9:627-630.
114. Kapsogeorgou E.K., Gourzi V.C., Manoussakis M.N., Moutsopoulos H.M., Tzioufas A.G. Cellular microRNAs (miRNAs) and Sjogren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 2011, 37:129-135.
115. Chagnon P., Schneider R., Hebert J., Fortin P.R., Provost S., Belisle C., et al. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum 2006, 54:1270-1278.
116. Miozzo M., Selmi C., Gentilin B., Grati F.R., Sirchia S., Oertelt S., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007, 46:456-462.
117. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000, 106:R75-R81.
118. D'Alessandro E., Di Cola M., Lo Re M.L., Ligas C., Vaccarella C., D'Andrea F., et al. Nonrandom chromosome changes in multiple sclerosis. Am J Med Genet 1990, 37:406-411.
119. Ortiz-Romero P.L., Corell-Almuzara A., Lopez-Estebaranz J.L., Arranz F.R., Ruiz-Contreras J. Lupus like lesions in a patient with X-linked chronic granulomatous disease and recombinant X chromosome. Dermatology 1997, 195:280-283.
120. Scofield R.H., Bruner G.R., Namjou B., Kimberly R.P., Ramsey-Goldman R., Petri M., et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008, 58:2511-2517.